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Introduction 
For the past 10 to 20 years, drug consumption rooms (DCRs) have become an integrated 
part of the drug treatment and harm reduction 
strategy in a variety of countries in Western 
Europe, North America and Australia. However, 
they have not yet been established in the 
majority of countries worldwide. 
This briefing paper provides a short summary of 
the background, history and objectives of DCRs, 
and analyses available evidence regarding their 
impact. The second part of the briefing paper 
consists of an overview of the various DCRs in 
different countries, with a particular focus on 
the concepts used to develop these facilities 
with regard to the local political, cultural and 
social situation of each country. 
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Background 
In the face of the burgeoning HIV epidemic 
among people who use drugs in the 1980s, 
the existence of open drug scenes in many 
Western metropolitan areas and rising numbers 
of drug-related deaths, some policy makers and 
practitioners have come to realise that repressive 
criminal justice measures and abstinence-based 
programmes alone were not able to reduce of 
drug use and associated harms. 
The implementation of harm reduction 
programmes such as needle and syringe 
programmes (NSPs), opioid substitution 
treatment (OST) and low-threshold services, 
as well as the emerging body of evidence of 
the effectiveness of these measures for public 
health and public order policies, became the 
starting point for considering the establishment 
of DCRs (see Box 2). 
Box 1. Methodology
The data presented in this report was provided by individuals working in DCRs in countries 
of focus. For most countries, data provided is country-wide. However, for countries such as 
Germany and Switzerland, where it has proven to be difficult to gather country-wide information, 
we have provided local or regional data.
2The late 1980s and early 1990s saw the early 
implementation of the first initiatives for DCRs 
in Switzerland, Germany and the Netherlands. 
Although these countries started experimenting 
with this new harm reduction measure, at 
the time DCRs were not officially included in 
national legislations.
In many instances, the driving forces behind 
the opening of DCRs were people who use 
drugs, harm reduction service providers or 
outreach workers, but also local authorities 
and law enforcement agencies. From the very 
beginning, DCRs were regarded as serving two 
main objectives: to reduce individual health 
risks associated with drug use, and to reduce 
public disturbance. 
In the 1990s, Switzerland, Germany and the 
Netherlands scaled-up DCRs to ensure wider 
access to the facilities. Meanwhile, DCRs were 
opened in Sydney, Australia and Vancouver, 
Canada in the early 2000s. Spain, Luxembourg 
and Norway complete the list of countries that 
have included these facilities in their drug policy 
and practice. However, only the Netherlands 
and Switzerland provide nation-wide coverage 
of DCRs for people who use drugs. In most 
countries, DCRs have only been established 
in the capital city (e.g. Australia, Canada, 
Luxembourg and Norway) or in specific regions 
(e.g. in Germany and Spain).
Box 2. Definition of ‘drug consumption room’
DCRs are protected places used for the hygienic consumption of pre-obtained drugs in a 
non-judgemental environment and under the supervision of trained staff. They constitute a 
highly specialised drugs service within a wider network of services for people who use drugs, 
embedded in comprehensive local strategies to reach and fulfil a diverse range of individual and 
community needs that arise from drug use. 
The aim of DCRs is to reach out to, and address the problems of, specific high-risk populations 
of people who use drugs, especially injectors and those who consume in public. These groups 
have important health care needs that are often not met by other services and pose problems for 
local communities that have not been solved through other responses by drug services, social 
services or law enforcement.1
In many other countries, efforts have been 
undertaken by service providers, politicians, 
researchers, grass-roots organisations and drug 
user advocates to introduce DCRs in their own 
country, most of them without success. One 
notable exception is that of Denmark. In 2011, 
a NGO in Denmark opened a mobile DCR in 
Copenhagen. For 10 months, this mobile unit 
provided services for people who use drugs 
without interference from the police or any 
other government authorities. The initiative 
significantly contributed to ongoing discussions 
regarding the legality of DCRs under Danish 
law. In June 2012, the Danish parliament 
passed a law giving municipalities a clear legal 
mandate to operate DCRs with permission from 
the Minister of Health.2
General settings
A DCR aims to fulfil several objectives: 
•	 to improve access to healthcare services 
for the most vulnerable groups of people 
who use drugs
•	 to improve their basic health and well-being
•	 to contribute to the safety and quality of life 
of local communities
•	 to reduce the impact of open drug scenes 
on the community. 
3Most DCRs are therefore embedded in a wider 
range of service provision and are implemented 
in collaboration with a variety of stakeholders, 
including local authorities, law enforcement 
officers, and social and healthcare service 
providers. In addition to the core services 
provided in the DCRs – supervised injection, 
NSP, basic healthcare and social and educational 
interventions – the visitors can also be referred 
to more extensive support services if necessary. 
Depending on the local circumstances, some 
DCRs may focus more intensively on a medical 
approach and choose to include medical doctors 
and nurses in their staff, while others may 
choose to play a ‘social function’ and focus on 
community outreach. All DCRs have established 
admission criteria and set out strict house rules. 
A number of DCRs have developed participation 
and peer-support models in order to include 
people who use drugs in service delivery and 
decision making processes. 
Legal contexts
A DCR operates within the legal system of the 
particular country in which it has been established, 
either as an independent legal entity, as a unit 
of a healthcare facility, as a non-governmental 
organisation (NGO), which is very common, or 
as part of a local governmental or public health 
service. In most countries, it has been necessary 
to modify specific laws in order to decriminalise 
drug consumption in the DCRs and to regulate 
the functioning of the rooms. In Canada and 
Australia, the DCRs have been set up as scientific 
pilot projects under legal exemptions. Despite the 
tolerated use of certain drugs in the facilities, the 
purchase of such drugs is criminalised in all of the 
countries that have developed DCRs.
At the international level, the United Nations (UN) 
drug control conventions may create an obstacle 
to the widespread introduction of DCRs.3 The 
International Narcotics Control Board (INCB), 
the UN body responsible for monitoring the 
implementation of the UN drug conventions has 
repeatedly expressed its concerns regarding 
the development of DCRs although its stance 
towards other harm reduction measures has 
softened over time.4 The INCB objects to DCRs 
on the basis that allowing the possession of 
drugs obtained through illicit means facilitates 
‘drug trafficking’ which must be established 
as a criminal offence.5 The INCB also argues 
that DCRs allow drug use that falls outside of 
scientific and medical purposes which therefore 
contravenes the conventions. However, this 
narrow interpretation of the conventions is not 
universally held. Indeed, responding to a request 
from the INCB to look into the relationship 
between a range of harm reduction measures 
and the drug control treaties, the forerunner of 
the United Nations Office on Drugs and Crime 
(UNODC) came to the conclusion in 2002 that 
many interventions, including DCRs, were not 
contrary to the conventions. This interpretation 
is supported by the interpretative flexibility of 
the conventions, a lack of definition of what 
exactly constitutes ‘medical and scientific’ 
purposes and language within the 1998 Political 
Declaration on the Guiding Principles of Drug 
Demand Reduction. In practice, therefore, while 
countries that have introduced DCRs have faced 
criticism from the INCB with regards to their 
international obligations, particularly within its 
annual report, this can easily be countered by 
robust legal justification.
 
The evidence for drug consumption 
rooms
DCRs are an innovative approach to reduce drug-
related harms, but remain controversial measures 
in the drug policy framework. It is therefore crucial 
to evaluate the effectiveness of these facilities 
carefully and continue to build the evidence base 
that justifies their implementation. The evaluation 
process is particularly used in countries where 
DCRs are still at the experimentation stage, such 
as in Australia and Canada. So far, however, 
broad-based randomised controlled trials and 
extensive studies on the cost-effectiveness of 
DCRs have not been achievable, mainly because 
methodological problems have made it difficult 
to justify the link between the existence of DCRs 
and the changes that have taken place in practice.
4The most recent extended evaluation report on 
DCRs was issued in 2010 by the accounting firm 
KPMG in Sydney, Australia, on the DCR trial 
period 2007-2011.6 The report suggests that:
•	 The DCR had a positive impact on reducing 
drug overdoses
•	 It functioned as gateway towards drug 
dependence treatment
•	 It reduced significantly the security 
problems related to injecting in public 
settings and discarded needles
•	 It contributed to a decline in new HIV and 
hepatitis C infections.
The European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA) published two 
extensive reports on DCRs.7 These reports 
reviewed available evidence about the effects 
of DCRs and concluded that they:
•	 Reach out to vulnerable groups and 
are accepted by their target groups, 
communities and other key actors
•	 Help to improve the health status of people 
who use drugs and reduce high-risk 
behaviour
•	 Can reduce overdose deaths
•	 May have an impact on HIV and hepatitis 
C virus infection rates, although more 
evidence is needed to prove this effect
•	 Can reduce drug use in open spaces and 
related nuisance, if this measure is part of a 
comprehensive local strategy.
The International Network of Drug 
Consumption Rooms
In 2007, the International Network of Drug 
Consumption Rooms8 (INDCR) was established 
in Bilbao, Spain. The objective of the INDCR 
is to share knowledge and experiences, to 
improve methodologies and to support the 
implementation of DCRs in new settings. The 
network delivers surveys and reports and aims 
to contribute to legal and political debates on 
DCRs. Currently almost all DCRs worldwide are 
members of the Network.
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Country DCR Eligibility and services Client profiles Results
Australia Location 
1 in Sydney
Staff 
1 in injecting room
Training: At least 
1 nurse, 3 officers 
with health training
Eligibility
18 years and over
Already drug dependent
Not pregnant nor with child
Not intoxicated
No dealing of drugs on premises
Services
Stage 1: Waiting room/assessment 
area
Stage 2: Injecting room  with 8 booths
Stage 3: After care room
Resuscitation room
Links to health, legal, housing, welfare 
services
12,050 clients between May 
2001 and April 2010
3 new clients a day on average
74% men / 26% women
33 years of age on average
13 years of average time 
injecting
Principal substances used
Drop in heroin use (40% in 
2005)
Increase in other opioid use 
(60% in 2012)
Decline in cocaine use (15% in 
2012)
10% methamphetamines
1-2% buprenorphine
Cost-effective
Contacts vulnerable groups – 
9,500 referrals to health and 
social welfare services
4,400 overdose interventions 
(no fatalities)
Reduced risk of blood-borne 
virus transmission 
Reduced public injecting and 
injection-related litter
No adverse impact on local 
community (e.g. increase in 
drug-related crime in area)
Canada Location
1 in Vancouver 
called ‘Insite’
Staff
9 staff
Training: nurses, 
programme workers 
(PHS), peer 
support workers
Eligibility
No admission criteria
Services
Low-threshold, anonymous service 
with 12 drug consumption booths
Supply of clean injection equipment 
and safer use counselling
Primary healthcare services 
Voluntary detox (Onsite) 
Links to longer-term drug dependence 
treatment programmes
Links to housing and community 
support
1.8 million visitors since 2003
Between 1st Jan 2010- 31st Dec 
2010:
312,214 visits by 12,236 clients
855 average daily visits
587 average daily injections
74% men / 26% women
17% identified as Aboriginal 
Principal substances used
36% heroin 
32% cocaine
12% morphine 
221 overdose interventions (no 
fatalities)
3.383 clinical treatment 
interventions
5,268 referrals to other social 
and health services
458 admissions to Onsite detox 
programme (completion rate in 
2010: 43%)
Reduced risk of blood-borne 
virus transmission 
Reduced public injecting and 
injecting-related litter
No adverse impact on local 
community
Germany Location
26 in 17 cities 
country-wide 
Staff
Number of staff 
variable according 
to size of DCR and 
financial constraints
Training: Doctors, 
nurses, educators, 
qualified student 
assistants and 
freelancers
Eligibility
Age eligibility varies according to state 
regulation
Already drug dependent
Not under OST (except in Hamburg)
Not intoxicated
Services
DCRs integrated with harm reduction 
facilities
Open between 3.5 and 12 hours a 
day
3 to 20 drug consumption booths
Links to medical and social services
In Frankfurt9 from 2003 to 2009:
Up to 4,700 visitors per year
26-35 years of age on average
85% men / 15% women
Principal substances used 
82% heroin 
36% crack10 
Since 1994, no drug-related 
deaths recorded in Germany
Increased client awareness of 
safer use techniques
Less drug-related health 
problems (e.g. fewer abscesses)
Data from North Rhine 
Westphalia (2001-2009):
3,271 drug emergency cases
710 CPRs
Luxembourg Location
1 in the City of 
Luxembourg called 
‘Abrigado’
Staff
23 multilingual staff
Training: Medical 
staff, psychologists 
social workers, 
educators, 
sociologists
Eligibility
18 years and over
Already drug dependent
Not under OST
Not pregnant or with child
Not intoxicated
No dealing of drugs on premises
Sign a ‘terms of use’ contract
Services
Integrated in low-threshold centre with 
7 injection booths
Pilot project ‘Blow room’ with 3 
inhalation booths
Open 6 days a week, 6h a day)
Night shelter (42 beds) and nursery
Drop-in centre (Kontakt Café) with 
primary medical care
On-site HIV/hepatitis C testing
Needle exchange programme
Safer use counselling
170,000 supervised drug 
consumptions (since 2005)
26,929 visits to DCR in 2011
207 average visitors per day 
(Kontact Café)
96 average visitors per day 
(DCR)
25-34 years of age on average
80% men / 20% women
Principal substances used
87% heroin
8% cocaine
5% mixtures 
1,025 overdoses successfully 
managed (no fatalities)
General decrease in overdose 
deaths and proportion of people 
who inject drugs in newly 
diagnosed HIV infection cases 
since the opening of the DCR
Citizens hotline established to 
encourage public acceptance 
of DCR
A few complaints from 
neighbouring communities 
recorded
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The 
Netherlands
Location
37 in 25 cities 
country-wide
Staff
3 staff members
Training: Medical 
staff, social workers, 
former drug users, 
security staff
Eligibility
Registered in city where DCR is 
located
Sign a ‘terms of use’ contract
No dealing of drugs on premises
Different admission criteria according 
to each DCR
Services
5 ‘stand-alone’ DCRs, others are 
integrated within low-threshold 
services
Separate rooms for injectors and 
smokers
15 booths for smokers, 5 for injectors
Medical and safer use counselling
24 clients per day on average
90% clients are non-injectors
45 years of age on average11 
90% men / 10% women12
Principal Substances used13
Heroin
Crack/coke base
Decrease in needle sharing 
Only 4% of new diagnoses of 
HIV, Hepatitis B and C among 
people who use drugs
HIV incidence rates among 
people who inject drugs 
dropped from 8.6% in 1986 to 
0% in 2000
94 acute drug-related deaths 
in 2010 with 20 non-municipal 
registered people
Significant decrease in public 
disturbance
High acceptance of DCRs 
(80%) by social/health 
providers, neighbourhoods and 
police
Norway Location
1 in Oslo
Staff
Minimum of 5 staff 
on duty during 
opening hours, 
including at least 1 
nurse.
Training: Nurses, 
auxiliary nurses and 
social workers
Eligibility
Heroin only substance allowed
18 years and over
Sign a ‘terms of use’ contract
Long term history of injecting heroin
Services
Limited to one dose of heroin per 
client per visit
Integrated with harm reduction 
services
Links with social and health services
Links to drug dependence treatment 
programmes
2,480 registered clients since 
2005
1,500 clients per year
109 clients per day on average 
(2011)
37 years of age on average
70% men / 30% women
Principal substances used
Heroin is the only substance 
allowed to be used in the DCR
Reduced perception of social 
exclusion among the user group 
Increased access to 
professional assistance in 
overdose situations
Increased access to health and 
social services
Spain Location
7 in 4 cities country-
wide, including 1 
mobile DCR
Staff
Number of staff 
variable according 
to each DCR
Training: 
multidisciplinary, 
with at least 1 nurse
Eligibility
18 years and over
Sign a ‘terms of use’ contract (in the 
Barcelona DCRs)
Services
3 DCRs allow smoking 
Links to social and health services
Links to drug dependence treatment 
programmes
In Barcelona: HIV testing and 
counselling, health care and social, 
psychological and legal support
105,804 visits from 5.063 clients 
(2009)
34 years of age on average
80% men / 20% women
Principal substances used
Cocaine most popular (except 
in Bilbao and Sala Balaurd in 
Barcelona, 2009)
Heroin most popular (Barcelona, 
2011)
Speedball most popular (Madrid, 
2011)
Decrease in overdose deaths 
from 1,833 in 1991 to 773 in 
2008
Decrease in new HIV infections 
among clients from 19.9% in 
2004 to 8.2% in 2008
High acceptance and demand 
for DCRs 
Reduced injection-related litter 
in public spaces
Community awareness about 
DCRs as a public health 
strategy
Development of common 
guidelines on harm reduction 
and DCRs
Switzerland Location
13 in 8 cities 
country-wide
Staff
No country-wide 
data
In Berne: 
Training: nurses and 
social workers.
Eligibility
18 years and over
Already drug dependent
Have official documentation
No dealing of drugs on premises
No consumption tolerated outside the 
DCR itself (e.g. cafeteria, toilets)
Services
Booths for intravenous use, smoking 
and sniffing (numbers vary according 
to the DCR)
Cafeteria with food and non-alcoholic 
beverages
Medical treatment
Consultations for social problems
Hygiene services (showers, provision 
of clothes)
NSP
Links to drug dependence treatment 
programmes and clinics
No country-wide data
In Berne:
38 years of age on average
992 registered clients a year
200 clients a day
74.1% men / 25.9% women
Principal Substances
No country-wide data
In Berne:
Heroin
Cocaine
Benzodiazepines
Cannabis
Substitutes
Alcohol
Decrease in drug-related deaths
Increased client awareness of 
safer use techniques 
Reduces risk of blood-borne 
virus transmission 
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Current political situation
The Sydney Medically Supervised Injecting 
Centre (MSIC)15 is Australia’s only DCR. The 
MSIC is administered by Uniting Care, a non-
government, Christian organisation that runs 
several community services in the state of New 
South Wales. 
In May 2001, MSIC opened its doors for a trial 
period of 18 months. The trial required an 
amendment of the Drug Misuse and Trafficking 
Act. It was extended three times so the MSIC 
operated under ‘trial’ conditions for nearly 
a decade, leading to the politicisation of the 
service and uncertainty about its future. In 
October 2010, the New South Wales Parliament 
passed legislation to end the MSIC’s trial status, 
making it a legitimate health service without 
needing an act of Parliament every four years to 
continue its operation.
There is no political support for further DCRs 
to be established in Australia. In May 2010, 
Melbourne’s inner city Yarra Council in the state of 
Victoria voted to establish a DCR because of the 
high prevalence of street injecting in the suburb 
of Richmond. The State Government rejected 
the idea immediately and the (opposition) 
Labour Party also refused to support it despite 
having advocated for DCRs in the past.
Regarding public support, the local community of 
Kings Cross in inner urban Sydney was already 
open to the concept of a DCR before the MSIC 
opened, and has become increasingly supportive 
since the service began. Australians in general 
have also been supportive of harm reduction 
measures and of DCRs specifically. In 2010 the 
National Drug Strategy Household Survey showed 
that the majority of Australians supported DCRs.  
Concept and objectives
The four objectives for the MSIC are to decrease 
drug overdose deaths, provide a gateway to drug 
dependence treatment and counselling, reduce 
problems associated with public injecting 
and discarded needles and/or syringes, and 
consequently reduce the spread of diseases 
such as HIV and hepatitis C.
Service provision 
MSIC clients must be aged 18 years or over and 
already have developed a dependence on drugs; 
they must not be pregnant, nor accompanied by 
a child; clients cannot sell, buy or share drugs 
in the centre or be intoxicated when arriving on 
the premises. 
The staff in the centres include at least one 
registered nurse (on an average day, there are 
usually three registered nurses), and officers 
with health training.
 
The MSIC operates a one-way client flow in 
three stages. Stage 1 is the waiting room and 
assessment area where clients are assessed for 
eligibility. Assessments include demographic 
information and medical history, including 
overdose and treatment history. Stage 2 is the 
injecting room that is staffed by at least two 
people, including a registered nurse, and has 
eight booths with two chairs, enabling the staff 
to supervise the injection procedure. Clients 
receive clean injecting equipment and advice, 
and first aid if required, including resuscitation 
in the resuscitation room. Clients place used 
equipment in sterile waste bins. Stage 3 is the 
after-care room where clients are observed 
until they are ready to leave. From the after-
care room they must leave the premises and 
they cannot re-enter the injection room. MSIC 
staff can also provide clients with links to health, 
legal, housing and welfare services.
Clients’ profile
From service commencement in May 2001 to 
the end of April 2010, 12,050 people who inject 
drugs registered with MSIC as clients with a 
monthly average of 111 new clients (with 3 new 
clients a day on average). Most clients are male 
(74%) with an average age at registration of 33 
years old. Clients usually have a long history of 
injecting drug use (an average of 13 years). At 
the time of registration, 70% were unemployed, 
approximately 35% had completed only 
8some secondary education, 16% were in 
unstable accommodation, and 23% had been 
imprisoned in the previous 12 months. 46% of 
all new clients reported that they had injected 
in a public place in the previous month, and 
40% had never accessed any drug dependence 
treatment before coming to the MSIC.
The types of substances used in the DCR have 
varied considerably since its opening. Between 
May 2002 and September 2005, heroin use 
declined from 80% to 40%, while other opiate 
use increased from 40% in May 2006 to 60% in 
January 2012. Cocaine use has largely declined 
since 2001 (when cocaine use was reported by 
50% of the clients) and stabilised at 15%. Finally, 
methamphetamine use has been reported by 
10% of the clients while buprenorphine use 
remains low (1 to 2% of the clients).
Results
The MSIC was independently evaluated16 
for nearly a decade by a number of different 
organisations. Eleven reports were released by 
five different agencies, all of which concluding 
that the DCR is meeting its objectives. More 
specifically, these reports show that MSIC is: 
•	 saving lives and reducing harms from drug 
overdose – the MSIC conducted 4,400 
overdose interventions, none of them 
leading to fatalities
•	 is making contact with a vulnerable and 
hard-to-reach group of people who inject 
drugs and referring them to relevant health 
services – a total of 9,500 clients were 
referred to health and social welfare services 
•	 is reducing the risk of blood-borne virus 
transmission
•	 is reducing public injecting and the number of 
syringes discarded in public locations – public 
injecting and injection-related litter have 
halved in Kinds Cross since MSIC opened
•	 is cost-effective, and is operating without 
any adverse impact on the local community.
Challenges and next steps
The challenge in Australia is for state and 
national political leaders to be courageous 
enough to contribute more positively to shifting 
the stigma associated with people who use 
drugs. Establishing DCR in other parts of 
Australia is an essential part of this to ensure 
that all people who use drugs have access to a 
DRC across the country.
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Political situation
According to the Canada’s Controlled Drugs and 
Substances Act (CDSA), the possession and/
or trafficking of certain controlled substances 
constitute a criminal offence. Section 56 of 
the Act gives the federal Minister of Health the 
authority to issue an exemption to ‘any person 
or class of persons’ from the application of 
sections of the Act if, in the Minister’s opinion, 
‘the exemption is necessary for a medical or 
scientific purpose or is otherwise in the public 
interest’. It is with such an exemption that the 
Canadian DCR, Insite, is able to operate. 
In September 2003, Vancouver’s regional health 
authority received a legal exemption from the 
federal Minister of Health to operate Insite, 
the first legally approved medically-supervised 
DCR in North America. The PHS Community 
Services Society operates Insite under contract 
with the health authority. In 2006, under public 
pressure, the new Minister of Health granted 
an extension for the exemption, first until 
December 2007, and then again until June 
2008. However, he rejected requests for a 
long-term solution permitting Insite to continue 
operating indefinitely.
Faced with the possibility of Insite’s closure, 
harm reduction activists began two court actions 
that sought to keep Insite open. The court cases 
challenged both the application of Canada’s 
drug laws to Insite and the laws themselves as 
being unconstitutional.  
9In September 2011, the Canadian Supreme 
Court issued a unanimous judgment ruling in 
favour of Insite.18 The Court was persuaded 
by evidence that people who use drugs are 
considerably safer administering their own 
injections under medical surveillance rather 
than injecting drugs on the streets.  As the 
Court succinctly declared, ‘Insite saves lives. Its 
benefits have been proven’. It ruled that shutting 
Insite would constitute an impermissible 
violation of the human rights of some of those 
who are most vulnerable. It ordered the Minister 
to grant an exemption to Insite immediately, in 
order to respect the constitutional rights of the 
DCR’s users and staff.
Concept and objectives 
Insite seeks to reduce the risks of disease and 
overdose death often associated with injection 
drug use; connect clients to drug dependence 
treatment and other health and social services; 
and reduce public drug use, injection-related 
litter and other related public disturbance 
problems.  
Service provision 
Insite is located in Vancouver’s Downtown 
Eastside (DTES), a neighbourhood that has a 
high concentration of poverty, of people affected 
by drug dependence and mental illness, and an 
open drug scene, including public injecting. 
The original exemption for Insite was based 
on feasibility data suggesting that a DCR could 
help reduce public drug use, overdose deaths 
and public disorder in the area. 
Insite is designed as a ‘low-threshold’ service.  All 
clients can remain anonymous, although client 
service use and outcomes are tracked at an 
individual level. As opposed to DCRs in most other 
countries, there are no admission criteria for clients 
wishing to go to Insite. The DCR was designed 
as a research pilot project (originally deemed 
necessary to obtain the original exemption from 
the CDSA), but participation in surveys and other 
aspects of the research into Insite’s operation and 
effects is optional for the clients.
The Insite staff are a mix of Vancouver Coastal 
Health and Portland Hotel Society employees, 
as well as peer-workers who are employed by 
L.I.N.E.S. (Life Is Not Enough Society).  2 nurses 
(VCH), 5 program workers (PHS), and 2 peer 
workers are present in the DCR at all times. In 
the injection room, the staff-to-client ratio is 
1:6, and in the ‘chill-out’ lounge, it is 1:10. 
Insite has 12 injection booths where clients 
can inject pre-obtained controlled drugs under 
the supervision of nurses and healthcare staff. 
Insite supplies clean injection equipment 
such as syringes, cookers, filters, water and 
tourniquets. If an overdose occurs, medical staff 
can intervene immediately. Nurses also provide 
other healthcare services, such as wound 
care and immunisations. Current protocols do 
not allow staff to assist directly with injection, 
although they educate clients about ways to 
reduce risks associated with injection.19
In addition, the facility includes Onsite, which 
consists of 12 rooms with private bathrooms 
where people can enter detox (including 
OST) on a voluntary basis, with support from 
mental health workers, counsellors, nurses and 
physicians. Once stabilised, people can move 
on to transitional recovery housing, also on-
site, and get connected to longer-term drug 
dependence treatment programmes, housing 
and community support services.
Clients’ profile
Since it opened in 2003, Insite received more 
than 1.8 million visits (by 12,236 clients), which 
represents an average of 855 visits daily. 74% 
of the clients were men, and 26% were women. 
17% of the clients were identified as aboriginal. 
The principal substances reportedly used in the 
DCR were heroin (36%), cocaine (32%) and 
morphine (12%).
Results
Insite has had more than 1.8 million visits since 
it opened in 2003, and there are more than 
12,000 registered clients. In 2010, there were:
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•	 An average of 587 injections daily 
•	 221 overdose interventions with no fatalities 
•	 3,383 clinical treatment interventions 
•	 5,268 referrals to other social and health 
services, the vast majority of them were for 
detox and drug dependence treatment 
•	 458 admissions to the Onsite detox service 
(which recorded a programme completion 
rate of 43% in 2010).20
Partly as a condition of its original exemption 
from Canada’s drug laws, Insite has been 
subjected to rigorous scientific evaluation. The 
research has produced more than 30 peer-
reviewed studies of the impacts of Insite, which 
demonstrate that the DCR:21
•	 is being used by those for whom it was 
intended, that is, those most at risk of 
overdosing or becoming infected with HIV or 
hepatitis C, and those who would otherwise 
inject drugs in public places
•	 has reduced HIV risk behaviour – people who 
use Insite are less likely to share injection 
equipment, and also have greater access to 
condoms and safer sex information
•	 promotes access to drug dependence 
treatment and other health services. In the 
first year after it opened, there was more than 
a 30% increase in the use of detoxification 
programmes among Insite clients. It also 
offers on-site care for injection-related 
infections and frequently connects clients 
with off-site medical treatment
•	 has improved public order – near and around 
the facility, there has been a measurable 
decrease in the number of injections done in 
public and in the amount of injection-related 
litter
•	 has reduced deaths from overdose – 
because medical staff are constantly present 
to respond to emergencies, no overdoses 
that have occurred at Insite have been fatal; 
modelling suggests that Insite may have 
prevented as many as 48 overdose deaths 
over a four-year period. It has also reduced 
overdose deaths within the surrounding 
neighbourhood by 35% in the two years 
after opening
•	 provides safety for women who inject drugs 
by providing a safe space away from the 
dangers of street-based drug scenes
•	 prevents more than 80 HIV infections per 
year and saves CDN $17.6 million in HIV-
related medical care.
Studies looking at potential harms of Insite have 
found no evidence of any negative impacts. 
Insite has not lead to increased levels of drug 
use, nor has it deterred people from stopping 
using drugs or seeking drug dependence 
treatment. In the area around Insite, there has 
been no increase in drug-related crime since 
Insite opened, and the rate of vehicle break-ins 
has decreased.
Challenges and next steps
The judgement by the Supreme Court of 
Canada in September 2011 has made it 
clear that the federal Minister of Health must 
entertain applications for exemptions to 
allow the operation of DCRs without risk of 
criminal prosecution. The Court identified 
some criteria that the Minister must take 
into account in considering each application. 
Following the decision, a number of community 
organisations in other cities have developed 
plans to apply for Ministerial exemptions, and 
several municipalities have expressed interest 
in establishing such facilities. In October 2011, 
it was announced that community agencies 
in Montreal and Quebec City would move 
ahead with plans for a number of sites, and the 
provincial Minister of Health has publicly stated 
support for those proposals, although some local 
community opposition has emerged. Feasibility 
studies have also been undertaken in Ottawa 
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and Toronto,22 although local politicians in each 
city have publicly declared their opposition to 
such facilities. It remains to be seen how the 
federal government will respond to requests for 
additional exemptions if and when they are filed.
Drug consumption rooms in Germany23
Current political situation
Large open drug scenes near major train 
stations, a high number of drug-related deaths, 
consumption in public spaces, and visible 
impoverishment in tourist attraction areas 
constituted the premises for more and more 
city residents, businessmen, law enforcement 
officers, and HIV and drug counsellors to argue 
for the establishment of DCRs in Germany.
 
The legal opinion of a public prosecutor and 
director of the Central Office for Combating 
Drug-Related Crime in May 1993 laid down 
the ground to get the already operating health 
facilities in Hamburg and Frankfurt legal within 
existing laws. The analysis formed the basis 
for the creation of a uniform federal regulation 
in 2000, amending the national Narcotics Act. 
Provinces were then given the opportunity, 
through local regulations, to establish a legal basis 
for setting up DCRs. As a result, German DCRs 
are anchored in local politics. The conditions of 
operation are discussed and agreed in regular 
meetings gathering local working groups 
composed of local government representatives, 
law enforcement officers, municipal health and 
social services and service providers.
Concepts and objectives
All DCRs are integrated in existing harm 
reduction facilities and aim to support social, 
mental and health stabilisation, to avoid blood-
borne infections and overdose casualties, and 
to provide timely referrals to other medical and 
social services. Strong emphasis is given to 
‘safe use’ regulations. DCRs also aim to reduce 
public disturbance. 
Service provision
Ten years after the reform of the Narcotics Act, 
not all provinces have adopted corresponding 
legal regulations and established DCRs. There are 
currently 26 DCRs available in 17 different cities.
Regarding admission criteria, people who are 
under opioid substitution treatment, are excluded 
from accessing DCRs (with the exception of 
Hamburg). New injectors and people intoxicated 
by alcohol or other substances are also denied 
access to the facilities. Some DCRs have an age 
requirement, which varies according to each state. 
In the Berlin DCR (in Lower Saxony), for example, 
the minimum age for accessing a DCR is 16.
The DCRs are opened between 3.5 and 12 hours 
a day and have a capacity of 3 to 20 clients.24 
DCRs are supervised by professional multi-
disciplinary staff, including doctors, nurses 
and educators, supported by qualified student 
assistants and freelancers (training-on-the-job 
and first-aid training for drug emergency cases). 
At least one employee is constantly present 
in most DCRs, enabling him/her to directly 
address the clients’ needs, provide safer use 
counselling and initiate emergency measures if 
necessary. 
The services provided at DCRs include:
•	 Distributing injection paraphernalia to 
ensure a hygienic consumption and lower 
health risks, in an anxiety- and stress-free 
environment
•	 Supervising of drug use and providing 
safer use counselling – safer use principles 
must be adhered to during consumption in 
a DCR. Safer use rules practiced in DCRs 
are often adopted in daily life and, as a 
result, successfully influence individual 
consumption behaviours. DCRs therefore 
provide an important bridge between 
healthcare provision and psychosocial 
support in a low threshold environment
•	 Offering a ‘contact centre’ for people who 
use drugs – in addition to distributing/
selling/exchanging drug consumption 
materials and condoms, many DCRs also 
regularly offer affordable warm meals and/
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or small snacks and beverages. Some DCRs 
also have showers and laundry facilities, 
and supply clothing to clients 
•	 Providing basic health care to clients, 
enabling physicians and/or nurses to 
intervene in case of crisis and provide first 
aid in case of overdose
•	 Providing advice and counselling – counselling 
is goal-oriented, and includes providing 
drug dependence treatment counselling and 
referral to treatment programmes (including 
detoxification programmes) supervised by 
qualified social workers.
DCRs are integrated within a wide range of HIV 
and drug facilities that provide counselling and 
a space to reach out to people who use drugs.
Clients’ profile
It has proven to be difficult to collect nation-wide 
data about clients in Germany. Between 2003 
and 2009, the frequency of visitors in the DCR 
in the Frankfurt DCRs rose by almost 50%, with 
up to 4,700 visitors per year. The average age 
of clients in is 26 to 35. The drug most widely 
used is heroin by injection, followed by crack. 
Drug use patterns in the DCRs in North Rhine 
Westphalia are slightly different, with a decrease 
in injecting and an increase of inhalation. 
Results
Available data clearly demonstrates the positive 
impact of DCRs on overdose cases and drug-
related deaths. DCRs have now been used by 
several million clients to date, and no drug-
related deaths have been recorded within the 
facilities. In North Rhine Westphalia, the largest 
province of Germany, a 2001-2009 survey 
documented 1.2 million consumption processes, 
among which DCR staff were responsible for 
responding to 3,271 drug emergency cases and 
performed 710 CPRs. Experience shows that 
the clients have less abscesses and are affected 
by less other drug-related health problems. They 
have also adopted safer forms of consumption 
in comparison to the people who inject drugs 
who do not use DCRs.
Challenges, next steps
The positive results, which can be drawn from 
the perspective of local authorities and DCR 
operators, support the expansion and further 
development of DCRs. The ultimate goal 
should be for all provinces to adopt appropriate 
regulations which allow the operation of DCRs, in 
order to ensure that people who use drugs have 
access to the facilities throughout the country. 
In the short term, it is essential that access to 
DCRs be extended to people under substitution 
therapy, as it is currently not the case in most 
German provinces. Admission criteria to the 
DCRs should therefore be revised to that end. 
Drug consumption rooms in Luxemburg25
Current political situation
Since 1999, the Luxembourg Ministry of Health 
has been entrusted with the national coordination 
of drug-related demand and harm reduction 
interventions. This led to the creation of the 
National Drug Coordinator’s office in 2000.
The 2009 government programme set the 
framework for the elaboration of the third 
National Strategy and Action Plan (2010-2014) 
on drugs and drug dependence. The current 
national Action Plan relies upon the priorities 
of the Ministry of Health and a sustained 
collaboration with field actors and civil society. 
The general objective of the National Strategy 
and Action Plan is to contribute to a high level 
of protection in terms of public health, public 
security and social cohesion. It relies on two 
pillars – demand reduction and supply reduction 
– and on four transversal axes: 1- Reduction of 
risks, harms and public disturbance; 2- Research 
and information; 3- International relations; and 
4- Coordination mechanisms.
The first DCR was established in the City of 
Luxembourg in 2005, within the framework of 
the second National Action Plan on Drugs for 
2005-2009 under the heading of ‘Reduction 
of risks, harms and public disturbance’. The 
Ministry of Health designed the original 
concept of the DCR and included the facility in 
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a financial convention with the ‘Comité National 
de Défense Sociale’ (CNDS) which was already 
managing a low-threshold centre for people 
dependent on drugs in the City of Luxembourg 
called ‘Abrigado’. 
The National Action Plan on Drugs anticipated 
the further development of harm reduction 
services in other regions of the country and, 
notably, the creation of a second DCR in the 
south of the country.
Concept and objectives
Before the DCR was established in Luxembourg, 
a needs-assessment study was conducted and 
concluded that harm reduction services needed 
further diversification to respond to the needs 
of people who use drugs in the country, who 
then mainly injected drugs. Opiate overdose 
deaths among people who inject drugs had 
been increasing for several years and there was 
a need to reach out to this highly marginalised 
group of users.
The philosophy of Abrigado is based on the idea 
that low-threshold and acceptance-oriented 
support will help to reduce risks and harms 
associated with drug use, and promote safer 
use. A major objective of the facility is therefore 
to respect the clients’ right to self-determination 
and to promote their self-responsibility. Of great 
importance in this approach is the fact that a 
purely medical approach to drug use would not 
meet the individual needs of the clients. The 
main focus of the DCR is not drug consumption 
itself but communication and the development 
of interpersonal relations. The DCR is therefore 
perceived as a ‘drug communication room’. 
Service provision
There are a number of criteria to be fulfilled 
for clients to have access to the DCR. Clients 
must be 18 years and over, already be drug 
dependent and not under OST, they should not 
be already intoxicated when arriving in the DCR 
and are not allowed to deal in the promises. 
Pregnant women or users with children are 
denied access to the facility. Finally, all clients 
must sign a ‘terms of use’ contract when they 
first arrive at the DCR.
The DCR in the City of Luxembourg currently 
has capacity for 7 simultaneous supervised 
injections. A pilot project offering 4 additional 
spaces for smoking or inhalation started in 
February 2012. The centre also hosts a night 
shelter with a capacity of 42 beds, a nursery 
(healthcare) and a drop-in centre called the 
‘Kontakt Café’ with a part-time medical service 
offering primary health care. Abrigado also 
participates in the national needle and syringe 
exchange programme.
The DCR and the Kontakt Café share the same 
opening hours – both are opened three days a week 
in the morning (for 6 hours) and three days a week 
in the afternoon (for 6 hours). Two staff members 
are permanently present in the DCR. They are 
assisted by the six employees of the Kontakt 
Café. The Abrigado team (23 staff members) is 
multidisciplinary and include psychologists, social 
assistants, educators, sociologists, a doctor and 
nurses who are multilingual (Luxembourgish, 
French, German and English) to account for 
the multiple and diverse social and linguistic 
backgrounds of the clients.
Clients’ profile
There were approximately 170,000 supervised 
consumptions since the opening of the DCR 
seven years ago, and about 1,200 clients have 
signed a DCR user contract. The average number 
of visits per day is 96 (including repeated visits). 
In 2011 alone, there were a total of 26,929 visits 
to the DCR. Only one third of the Kontakt Café 
visitors use the DCR. The ratio of male to female 
clients in the DCR is 80%/20%. Most clients 
are aged 25 to 34 years old (44%), and 35 to 
44 years old (37%). The age group of clients 
aged 18-24 only represents a proportion of 9%. 
Heroin is the most commonly used substance in 
the DCR (87%) followed by cocaine (8%).
Results 
Public acceptance of the DCR is an ongoing 
process. Abrigado provides a permanence phone 
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number for residents in the neighbourhood to 
allow them to report any incidents, problems 
or disruption they witnessed. A cooperation 
committee composed of delegates from the 
Ministry of Health, the Ministry of Justice, 
the Public Prosecutor’s Office, the City of 
Luxembourg, law enforcement authorities and 
other specialised drug agencies, also meets 
on a regular basis to support the project and to 
rapidly solve emerging problems. Thus far, only 
a few complaints from neighbouring citizens 
have been recorded.
In 2009 an external evaluation of the Action 
Plan on drugs for 2005-2009 was performed 
by the Trimbos Institute based in the 
Netherlands.26 The evaluation states that: ‘The 
injecting room […] is judged as ‘positive’ by the 
stakeholders. It is functional and its capacity is 
seen as sufficient’. Indeed, the functioning of 
the DCR has been accompanied by an overall 
decrease in overdose cases in the Grand-Duchy 
of Luxembourg. 1,025 overdoses (one third 
with loss of consciousness) were managed 
successfully with no fatalities since 2005. Safer 
use counselling, on-site testing for HIV and 
hepatitis C and the implementation of an on-
site primary medical care service also greatly 
contributed to reducing drug-related harm. 
The opening of a ‘blow room’ offering 3 places 
for inhalation in February 2012 will provide 
clients with the option to switch to less harmful 
use patterns of use.
Challenges and next steps
In early 2012, Abrigado moved into new facilities 
which provide 4 places for inhalation in addition 
to the already existing spaces for intravenous 
consumption. The move to a new facility has 
been accompanied by a change of name for the 
institution in order to avoid stigmatisation of the 
target group. It changed from its original name 
‘Tox-in’ to ‘Abrigado’. 
Future challenges include optimising networking 
with other institutions and increasing the number 
of DCR impact studies by further developing and 
monitoring evidence-based measures. In order 
to make services more efficient, DCRs should 
also focus on tailoring services to specific target 
groups such as women, young people and 
clients with co-morbidity.
Finally, DCRs should be made available to a 
wider number of people, in more geographical 
areas. To meet this challenge, the Ministry of 
Health is currently planning to open a second 
DCR in the south of the country. 
Drug consumption rooms in the 
Netherlands27
Current political situation
In 1990, a church-operated social institution 
in Rotterdam began to allow people to 
consume drugs on its premises. It was not 
until 1994 that this became a regular part of 
the services provided by the institution. The 
establishment of official DCRs became possible 
with the development of legal guidelines by 
the College van Procureur-generaal in 1996. 
These guidelines clarified that the possession 
of controlled drugs in DCRs was tolerated 
provided that the facilities fit into the local drug 
policy framework as defined by the mayor, the 
police and the public prosecutor.28 
Today, DCRs constitute an integral part of the 
harm reduction response in the Netherlands. In 
the past decade, the profile of people who use 
drugs has changed with an increasing number of 
smokers, cocaine users and alcohol users. There 
has also been a shift in focus within public health 
policies – the approach towards drug use is now 
embedded in general healthcare provision and is 
multidisciplinary, taking into account the social, 
legal and health situation of a person.29
Concept and objectives
DCRs in the Netherlands have a limited number 
of registered clients from a well-defined target 
group – mainly homeless people. However, some 
DCRs have wider access criteria or target specific 
vulnerable population groups, such as immigrants 
or sex workers. The general objective is to provide 
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a safety net for these vulnerable groups, to reduce 
public disturbance, and to improve the welfare 
and health status of individuals. 
Service Provision
Starting first with a few DCRs in 1995, the number 
of DCRs increased significantly between 2001 
and 2005. In 2010, 37 facilities were registered 
in 25 different cities. Most rooms are integrated 
in facilities providing low-threshold services, 
while five of them are ‘stand-alone’ DCRs.
To access a DCR, certain criteria have to be 
fulfilled. There is a minimum age requirement 
to access the DCR and the individual must be 
registered in the city where the DCR is located. 
The client must sign a contract to agree on the 
house rules and should already possess the 
drug before entering the premises (dealing is 
not allowed in the premises). Not all rooms have 
the same regulation rules and many are flexible 
in their implementation. 
Most rooms have staff comprising medical and/
or social workers and a third of the facilities 
have ex-drug users working as staff. Rooms 
are usually open every day, for up to 15 hours 
a day. The time a client is allowed to stay per 
visit is limited – from 20 minutes to two hours. 
Most DCRs have separate rooms for smokers 
and injectors. The average number of places 
is 15 for smokers and 5 for injectors. In the 
early years of functioning of the DCRs, the 
police used to refer 75% of the clients to the 
room. In 2010, however, that number dropped 
to 47%. 75% of the rooms have some form of 
client participation, involving them in the daily 
routine and in decision making processes. Most 
of the DCRs offer practical support, medical 
counselling and training on safer use.
Clients’ profile
The average number of clients is 24 per day 
(ranging from 2 to 60). The number of clients 
to the DCRs has decreased in the last couple of 
years, because of a decrease in the number of 
targeted individuals and changing patterns of 
drug consumption. Today, 90% of the clients 
are non-injectors. Clients are 45 years of age on 
average, and 90% of them are men.30
Results
There has been no rigorous evaluation regarding 
the impact of DCRs over a certain time period. 
However the overall results are generally 
regarded as positive31:
•	 Public disturbance related to drug use, 
such as dealing and using in the streets, 
decreased significantly
•	 There was an important shift from injecting 
to smoking – only 10% of DCR clients now 
inject drugs. Although there was an increase 
in smoking, this has led to a significant 
decrease in needle sharing
•	 Recent research shows that acceptance of 
the DCRs by social and health care providers, 
the neighbourhood and the police is very 
high in the areas where DCRs have been 
established (more than 80%)
•	 There are very low infection rates of HIV and 
hepatitis C among DCR clients.
Challenges and next steps
The objective of the Dutch policy is to implement 
social and health based programmes to reduce 
the number of people included in the target 
group who has access to the DCRs (i.e. homeless 
people who use drugs) to eventually make 
DCRs unnecessary. However, this might create 
problems for vulnerable and hard-to-reach 
groups of people who use drugs as many may 
continue to use drugs problematically despite 
social and health programmes, and therefore 
continue to need DCRs. It is necessary that the 
government continues to support DCRs as a 
long-term harm reduction strategy. 
In addition, particular groups in the Netherlands 
do not have access to DCRs, even though they 
are at risk of health-related problems and 
of causing public disturbance. This includes 
young people who use drugs, users who do 
not live in the street, people dependent on 
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both drugs and alcohol, and users who are not 
officially registered in a particular city, such 
as illegal migrants. It is necessary to broaden 
the admission criteria so that these vulnerable 
groups also have access to the DCRs.
Another challenge is the rise in alcohol 
dependence among people who use drugs and 
how to deal with the related issues. Alcohol 
consumption is currently allowed in only 25% 
of the DCRs.
Finally, there are concerns, in the current political 
and economic context, that public and political 
support for the DCRs may decrease and budget 
cuts may take place. This would put the country 
at risk of losing the benefits created by the 
successful implementation of the government’s 
integrated harm reduction approach.
Drug consumption rooms in Norway32
Current political situation
The supervised drug injection facility in Oslo, 
Norway, was opened on 1st February 2005 after 
years of political debate. The DCR was established 
as a three year trial under temporary legislation, 
which was prolonged until a permanent legislation 
was passed in 2009. Initially, the DCR was located 
within a low-threshold health clinic and a needle 
and syringe exchange programme, but was 
subsequently relocated to a more suitable stand-
alone location in 2007. 
Concept and objectives
The objective of the DCR is to increase the dignity 
of people with a long-term history of injecting drug 
use, by providing a hygienic and safe environment 
to inject heroin. The DCR aims to provide a 
multidisciplinary specialised model to improve the 
health status of people who inject drugs through 
the presence and supervision of healthcare 
workers in order to prevent injection-related 
infections, to assist in case of overdose, and to link 
the client with other social and health services and 
drug dependence treatment programmes.
Service Provision
The DCR is operated by the Oslo Municipality’s 
Agency for Alcohol and Drug Addiction Services, 
and is jointly funded by the Oslo Municipality 
and the Norwegian Directorate of Health. The 
injection room in Oslo is the only facility of its 
kind in Norway – no other municipality has yet 
chosen to follow Oslo’s example. 
Under Norwegian legislation, heroin is the only 
substance allowed to be used in the DCR. Clients 
have to register and sign a contract containing 
the terms of use of the facility. All users have to be 
over 18 years of age, and must have a long-term 
history of injecting heroin use. The legislation 
limits the use of the DCR to the injection of one 
dose of heroin per client per visit. 
The room is open from Monday to Thursday 
between 9:00am and 7:30pm and from Friday 
to Sunday between 9:00am and 3:00pm. The 
DCR staff is multidisciplinary, including nurses, 
auxiliary nurses and social workers, and there 
is always at least one nurse on duty during the 
DCR’s opening hours. The DCR is integrated with 
other harm reduction services and staff members 
can refer clients to social and health services, as 
well as drug dependence treatment programmes.
Clients’ profile
2,480 registered clients have used the DCR 
since it opened in 2005, and about 1,500 of 
them use the room each year. In September 
2011, an average of 109 clients used the room 
every day. Approximately 70% of the clients 
are men and the average age of the clients is 
37 years old. Less than 1% of the injections that 
took place in 2011 have led to an overdose.
Results
The DCR in Oslo was evaluated by the Norwegian 
Institute for Drug and Alcohol Research (SIRUS) 
in 2007 and 2009.33 The two evaluations were 
carried out when the room was operating in two 
different locations, reflecting the importance 
of suitability of infrastructure. Both evaluations 
conclude that the objectives are difficult to 
evaluate. However, they both point out that the 
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DCR increased the promotion of the dignity of 
the group in question, both generally and for the 
individual. Findings also concluded that clients 
felt less socially excluded. The DCR also increased 
access to health and social services, and to 
professional assistance in case of overdose.
Challenges and next steps
The main challenge today is linked to the 
strict admission criteria which limit access to 
the DCR. This includes the fact that only one 
injection of heroin is permitted for each client 
per day, while the amount of heroin that can be 
injected is often disputed. People who use other 
drugs, combine heroin with other substances or 
wish to inject more than once a day, and those 
who consume drugs through smoking, snorting, 
inhaling, etc. are also excluded from the DCR. 
The minimum age limit of 18 also automatically 
excludes young people who use drugs, who are 
usually highly vulnerable to drug-related harms. 
Finally, only people who have a ‘severe heroin 
dependency’ have access to the DCR, which 
presents challenges as the status of ‘severe 
heroin dependency’ is not clearly defined. 
Another major challenge is the difficulty for the 
DCR staff to refer clients to adequate social, 
health and treatment services. The DCR will be 
relocated in 2012 within other services, which 
will hopefully strengthen links with other social 
and healthcare services and increase access to 
drug dependence treatment facilities.
Drug consumption rooms in Spain34
Current political situation
As drug policies are decentralised in Spain, it is the 
responsibility of regional and local governments to 
develop services for people who use drugs.35 Drug 
trafficking is considered as a crime in the Spanish 
penal code. The use of controlled drugs and leaving 
injection equipment in public spaces is not a crime 
but it is a serious misdemeanour that can result 
in a fine of between 300 to 30,000,000 euros. 
This fine can, however, be replaced by alternative 
measures, including drug dependence treatment. 
Under the law there is no legal impediment for the 
development of DCRs. At the national level, DCRs 
are supported by the National Agency of Drugs, the 
National Agency on AIDS and the corresponding 
regional and local institutions.
The first Spanish DCR opened in 2000 in Madrid. 
Today there are seven of these facilities in four 
different cities (Barcelona, St. Adrià del Besòs, 
Bilbao and Lleida). Six more safe injection 
facilities are planned to open in Barcelona within 
already existing drug treatment centres over 
the course of 2012. For political and financial 
reasons, the DCR ‘Dave’ located in Madrid 
closed at the end of 2011. 
DCRs in Spain commonly belong to the local 
and regional Health Ministries and agencies, 
such as Sala Baluard, which belongs to the 
Public Health Agency of Barcelona.36 One DCR 
in Spain – CAS Vall d’Hebrón in Barcelona – 
belongs to the National Health Service, and 
is located in a public hospital. The rest of the 
DCRs – Munduko Medikuak, SAPS, La Mina 
and Arrels – are not directly linked to the public 
health system but work in collaboration with 
it. All DCRs in Spain receive public funds from 
different public administrations.
Most of the DCRs are managed by NGOs – 
Fundació San Ignasi de Loyola, Fundación IPSS 
Instituto para la promoción social y de la salud, 
Institut Català de la Salut , Servicio de Psiquiatría 
del Hospital Universitario de la Vall d’Hebron, 
Asociación Bienestar y desarrollo, Médicos del 
Mundo and the Red Cross. 
Concept and objectives
DCRs throughout Spain share common 
objectives. As with most DCRs operating in other 
countries, they aim to promote safer drug use 
by providing more hygienic drug consumption 
conditions. Spanish DCRs also seek to:
•	 promote safer use through the provision of 
more hygienic conditions
•	 supervise and provide counselling services 
to clients before, during and after drug 
consumption
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•	 offer social and health care, and refer clients 
to appropriate social, healthcare and drug 
dependence treatment services
•	 gather data on new drug use patterns, 
emergent problems or needs among people 
who use drugs
•	 raise awareness among the community 
about the need and benefits of DCRs as a 
public health strategy
•	 reduce drug use in public spaces.
Service Provision
To access the DCRs, the clients need to be aged 
18 and over. In Barcelona, clients also need to 
sign a ‘terms of use’ contract to access the DCRs. 
Three DCRs offer booths to clients who smoke 
drugs, while all others are only used for drug 
injection. Facilities have multidisciplinary staff 
(including at least one nurse) who supervise and 
provide safer use counselling to clients during 
all stages of drug consumption. Staff can also 
refer clients to social and healthcare services 
or drug treatment centres. In Barcelona, the 
DCRs also offer HIV testing and counselling and 
social, psychological and legal support.
Clients’ profile
In 2009, Spanish DCRs had a total of 105,804 
visits from 5,063 clients.37 The average age of 
clients in Spanish DCRs is 34 years old (28 to 
38), about 80% of them are men. The majority 
of clients are Spanish or European, but a great 
number also come from Eastern Europe and 
North Africa. In 2009, cocaine was the most 
popular drug used (except in Bilbao and Sala 
Balaurd in Barcelona), but in 2011 this was 
surpassed by heroin in DCRs in Barcelona. The 
DCR in Madrid was the only one to register 
speedball as the most used substance, before it 
closed its doors last year. Injection remains the 
most common way to use drugs in DCRs, except 
Bilbao where inhalation is more frequent.
Results
In Spain DCRs are well accepted and are in high 
demand from harm reduction professionals, 
health and social service providers, and people 
who use drugs. Since these facilities opened:
•	 overdose deaths have decreased from 
1,833 in 1991 to 773 in 2008
•	 the number of new HIV infections has also 
decreased among DCR clients from 19.9% 
in 2004 to 8.2 in 2008 
•	 users’ awareness of safer injection 
techniques has improved
•	 community awareness about DCRs and the 
country’s public health strategy towards 
drugs has increased
•	 injection-related litter in public spaces was 
reduced.38
Another important achievement includes the 
development of common guidelines on harm 
reduction and DCRs, the active participation of 
Spanish DCRs in the International Network of 
Drug Consumption Rooms,39 and constructive 
interactions with the local community. 
Challenges and next steps
One of the main challenges in Spain is the need 
to reconsider harm reduction as a more holistic 
intervention among people who use drugs. DCRs 
and harm reduction services should be normalised 
at political and social level by integrating 
DCRs into a public healthcare network. More 
comprehensive services such as harm reduction 
based healthcare should be expanded and there 
should be a greater attention given to the social 
needs of long term and chronic users. 
The welfare of the client and the working 
conditions of staff should always remain 
paramount – services should, for example, 
improve the social conditions of people who 
use drugs who are already in a socially deprived 
19
situation. The incorporation of a substance 
analysis service into DCRs would have the 
potential to provide more information about 
drug use patterns, and increase the health 
and safety of people who use drugs. It is also 
important that referrals to OST be facilitated.
There should also be a greater number of DCRs 
available for smoking users (with the ability to 
distribute smoking paraphernalia), and DCR 
opening times and locations should also be 
extended. 
Monitoring and evaluation of DCRs through 
data collection and an assessment of harm 
reduction services also need to be improved. In 
the current economic climate, it is essential that 
DCRs and harm reduction programmes become 
consolidated and stabilised.
Drug consumption rooms in 
Switzerland40
Current political situation
The world’s first DCR was opened in 1986 by 
Contact Netz in Bern, Switzerland. At the time, it was 
becoming clear that strategies focused exclusively 
on repressive measures and abstinence could not 
cope with the high level of new HIV infections, the 
increasing numbers of drug-related deaths and 
the open drug scene in the city. The creation of the 
DCR was a paradigm shift in drug policy, creating 
a radical new approach to the drug epidemic at 
the political, health and social level. Contact Netz 
started providing medical and social services, 
including needle and syringe exchange, warm 
meals and shelter. DCRs were subsequently set up 
in several other cities in Switzerland and open drug 
scenes disappeared. 
DCRs are now accepted and supported by most 
political parties in the country. The latest federal 
vote in 2008 concerning the revision of the 
national narcotics law showed a clear acceptance 
of harm reduction policies and programmes by 
the public, and the term is now included in the 
Swiss federal drug policy system – the Swiss drug 
policy is based on four pillars: law enforcement, 
treatment, prevention and harm reduction.
Concept and objectives
The fundamental objectives of Swiss DCRs 
are to provide people who use drugs social 
and healthcare services, improve the health of 
people dependent on drugs and reintegrate them 
into society. DCRs also seek to reduce public 
disturbance created by drug use in public areas. 
Service Provision
There are 13 DCRs in 8 cities in Switzerland, 
most of them in the German part of the country. 
DCRs reach out to, and are accepted by, their 
target population. 
In 2011, national standards were developed for 
all DCRs in Switzerland.41 These new standards 
provide guidelines on the provision of services, 
including HIV and hepatitis prevention and 
care, general health care (drug dependence 
treatment, voluntary counselling, and services 
to improve hygiene and treat abscesses) and 
the good functioning of the DCRs, such as the 
admission criteria and rules. 
Entry admission criteria include a minimum 
age of 18, drug dependency (occasional users 
do not have access to the DCRs) and being in 
possession of official documentation. Rules 
that must be followed include no violence, no 
dealing on the premises and no consumption 
outside the DCR (such as in the cafeteria or in 
the toilets). House rules also include guidance 
on the the conditions of the DCRs,  the working 
conditions of staff members, the evaluation 
instruments to control the quality of the services, 
legal protection of data, and public networking 
and collaboration with the police.
The staff is composed of nurses and social 
workers. Services include booths for intravenous 
use, smoking and sniffing, a cafeteria providing 
food and non-alcoholic beverages, healthcare 
services, consultations for social problems, 
hygiene services (such as showers and the 
provision of clothes), NSPs, and referrals to 
drug dependence treatment programmes and 
clinics for those clients who request it. 
Clients’ profile
It is difficult to collect nation-wide data 
regarding the profiles of the clients in DCRs. In 
Berne, the majority of clients in DCRs are male 
(74.1%), over 35 years old and have a long 
history of drug use. The drugs most commonly 
used are (in order of popularity) heroin, cocaine, 
benzodiazepines, cannabis, substitutes and 
alcohol. In a low-threshold DCR in Geneva, 
the ratio between men and women is 72.2% / 
27.8%, the average age of clients is 32, and they 
mostly inject cocaine and heroin.42
Results
After the introduction of DCRs, the number of 
drug-related deaths has decreased. Several 
studies have demonstrated the effectiveness of 
DCRs in reducing HIV or hepatitis C virus infections 
among people who use drugs. Positive changes 
were also observed in injecting behaviours and 
hygiene for many clients. This was confirmed by 
several surveys in Switzerland concluding that 
syringe sharing had decreased in the country.43
Challenges and next steps
Harm reduction and low-threshold facilities 
have adapted their services to the changing 
needs of their clients, in order to respond to 
changing patterns in consumption, substances 
and differential services for special target 
groups such as young users and older users 
with a long history of drug use.
For example, 18 months ago there was a 
significant shift in the strategy of Contact 
Netz. This shift resulted in a move away 
from acceptance-oriented harm reduction to 
development-oriented services. The anonymity 
of clients was lifted to gather more information 
about the situation of target groups and to enable 
predictability during the care process. The shift 
led to target-group-oriented services, including 
the provision of a daily structure for older, long-
term users or special counselling for younger 
users instead of integrating them into treatment 
programmes outside the DCR. The experiences 
of these shifts in functioning have been positive. 
Collaboration with other service providers has is 
also becoming more efficient over time.
Political support and good networking and 
constructive cooperation with the local police 
are also necessary for the long-term existence 
of DCRs, and there is room for improvement in 
that domain.
Conclusions and remaining 
challenges
DCRs are at the frontline of discussions in 
the harm reduction and drug policy field. 
Although available evidence suggests that 
these facilities have a positive impact on the 
health and well-being of individual users and 
the wider community, many policy makers and 
mainstream media function as a barrier to the 
introduction and/or scaling up of DCRs. Recent 
initiatives for the need of opening such  rooms 
started in Antwerp, Belgium, Marseille, France, 
Torino, Italy, the United Kingdom and others, 
with no concrete move forward so far. The only 
exception to this is the experience of Denmark, 
where the Parliament has recently passed a 
law which creates the legal foundations for the 
development of DCRs in the country. 
It is worth noting that although public opinion 
is generally against the introduction of such 
facilities, public acceptance of DCRs is 
considerably high in most of the locations where 
they have been established, as health problems 
have been reduced, and law and order have been 
improved. Communities, neighbourhoods and 
local authorities are usually involved in the good 
functioning of the facilities through cooperation 
and communication. The involvement of people 
who use drugs in the design and running of the 
facilities is an essential part of the acceptance 
and success of the initiative as well.
In terms of effectiveness, it seems clear that 
as consumption patterns evolve DCRs will 
need to adapt their services to those new ways 
of consuming (inhaling, smoking) and new 
substances being used (such as ‘legal highs’) by 
potentially new target groups (such as younger 
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users). The challenge for DCRs is to adapt to 
the new realities in order to provide adequate 
services to people who use drugs.   
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